A comprehensive view of GlobalData Plc. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Housing & Economy Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

GlobalData: Iced and speciality coffee drinks trend driven by millennials/Gen Z, who prefer on-the-go beverages with added functional benefits like instant caffeine boost; demand also growing for small pack sizes, such as single-serve instant coffee pods
Published: April 18, 2024 by GlobalData Plc
GlobalData expects rigid plastics to grow at 2.6% CAGR from 2023 to 2026, but innovative materials and processes are helping food and beverage industry reduce plastic in product packaging; report highlights efforts by PepsiCo, Danone, Coca-Cola, Starbucks
Published: April 18, 2024 by GlobalData Plc
GlobalData: Eli Lilly set to reshape pharmaceutical landscape with obesity and Alzheimer's treatments, Mounjaro and donanemab; both drugs poised to beat market expectations, with Mounjaro's sales poised to reach US$34B in 2029, more than double Wegovy's
Published: April 17, 2024 by GlobalData Plc
GlobalData predicts GLP-1 drugs will redefine big pharma sales; Eli Lilly's diabetes drug, Mounjaro, is forecasted to generate US$34.0B by 2029, surpassing the entire 2023 portfolio of Lilly, with the Alzheimer's drug donanemab adding another US$5.0B
Published: April 17, 2024 by FiercePharma
GlobalData: US obesity drug market set for surge with 13 new launches projected over next five years; Novo Nordisk to lead with six launches, including Cagrisema that's expected to launch in 2025 and generate US$7.4B by 2029
Published: April 16, 2024 by Outsourcing-Pharma.com

Ask us about our Housing & Economy market view

Trending Chart

Interactive chart with headline count